Reprocell

Leading global supplier of iPS-derived cells, stem cell reagents, human biofluids, and 3D cell culture.

placeOsaka, Osaka, Japan calendar_todayFounded 2003 groups123 employees language reprocell.com

Registered entities

Innovation

23 patent families (7 granted) — focus: Chemistry & metallurgy, Operations & transport, Human necessities, Physics & computing; filing pace steady. Cited 444 times.

YearFilings
20125
20132
20144
20151
20166
20172
20181
20221
20241

Social engagement

Social engagement: 8.4K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

6 investors on record.

Investor typeCountShare
Venture capital467%
Accelerator & incubator117%
Other / undisclosed117%

Recent activity

1 Jul 2026
Event
BIO 2026
26 Jun 2026
Event
ISSCR 2026
24 Jun 2026
Recognition
Coming soon